IFLR1000

Search results

Narrow your search

Result types
Article type
Jurisdiction
Practice area
Industry sector
Bar admission

Showing 3511 - 3520 of 7112 for "Investment funds" with applied filters

News & Analysis

Mexico: New partners announcement

22 December 2021 by Ritch Mueller y Nicolau

We are pleased to announce the following lawyers as new partners of our firm
News & Analysis

Switzerland: MLL strengthens its Competition, Corporate and M&A and China Desk competencies with the appointment of Renato Bucher, Florian Müller and Christian Rebell to the MLL partnership

16 December 2021 by MLL Meyerlustenberger Lachenal Froriep

MLL is delighted to announce that Renato Bucher, Florian Müller and Christian Rebell will become partners of the firm on 1 January 2022.
News & Analysis

Luxembourg: Arendt Appoints Christian Heinen As The New CEO Of Arendt Services Arendt appoints Christian Heinen as the new CEO of Arendt Services

15 December 2021 by Arendt & Medernach

Arendt is pleased to welcome Christian Heinen, who joined the group as the new CEO of Arendt Services on the first of December. He takes over for Olivier Hamou, who will remain on the company’s Board of Directors.
News & Analysis

New successful business combination for Luxembourg-incorporated and Frankfurt listed SPAC

14 December 2021 by Arendt & Medernach

Arendt advised 468 SPAC I SE, a Luxembourg special purpose acquisition company (SPAC) sponsored by Alexander Kudlich, former Rocket Internet board member, Ludwig Ensthaler and Florian Leibert, in its successful business combination with Boxine GmbH ("Boxine")
News & Analysis

Romania: NNDKP assists Safety Broker in the sale of an 80% stake to Unilink

13 December 2021 by Nestor Nestor Diculescu Kingston Petersen

NNDKP has assisted Safety Broker, the largest independent insurance broker operating in Romania and in the Republic of Moldova, in the sale of 80% of the company’s shares to the Unilink group, leader on the relevant Polish market.
News & Analysis

Olive trees restoration in Ancient Olympia Greece

10 December 2021 by Bahas Gramatidis & Partners

We kindly invite you to join our noble cause; the purchase of approx. 100,000 olive trees to replace the ones lost by the recent devastating fires in the surrounding of Ancient Olympia, Greece.
News & Analysis

Arendt assisted Alvotech with all Luxembourg law aspects of a business combination (de-SPACing) with Oaktree Acquisition Corp. II

10 December 2021 by Arendt & Medernach

Arendt assisted Alvotech with all Luxembourg law aspects of the agreement to enter into a business combination with Oaktree Acquisition Corp. II in order to create a leading publicly traded global biopharmaceutical company
News & Analysis

Luxembourg: Stéphanie Lhomme joins Arendt Regulatory & Consulting to enrich Arendt’s financial crime and forensic investigations offering

30 November 2021 by Arendt & Medernach

Stéphanie Lhomme has joined Arendt Regulatory & Consulting in the role of Director in order to strengthen Arendt’s advisory services offering to clients in the areas of Forensic Investigations, Anti-bribery & Corruption, and Corporate Intelligence.
News & Analysis

India: Carlyle Group’s investments in Viyash Life Sciences Private Limited, an integrated generic pharmaceuticals platform

24 November 2021 by L&L Partners

L&L Partners Law Offices advised the Carlyle Group (“Carlyle”), on setting up an integrated generic pharmaceuticals platform, known as Viyash Life Sciences Private Limited in partnership with ex-Mylan senior executive, Dr. Hari Babu Bodepudi and ex- founder of Laurus Labs, Dr. Srihari Raju Kalidindi. L&L has also advised Carlyle on all its follow-on investments into Viyash over a period of time.
News & Analysis

India: Carlyle Group’s generic pharma platform Viyash, invests in Appcure Labs and Appco Pharma LLC

24 November 2021 by L&L Partners

L&L Partners Law Offices advised the Carlyle Group on the acquisition of 100% stake of Appcure Labs Private Limited and the acquisition of majority stake in Appco Pharma LLC through its generic pharma platform, Viyash Life Sciences Private Limited.
Load more